- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
American Cancer Society Changes Its Screening Guideline Process
The American Cancer Society has revised the process it uses to create guidelines for cancer screening to make the guidelines more clear and consistent and to help people better understand how such decisions are made.
Many people in the general public and healthcare profession, as well as policy makers and insurance companies, use American Cancer Society screening guidelines to make important health decisions. Other organizations, however, also write cancer screening guidelines. Sometimes these different guidelines conflict, even when they’re based on the same information. So, the Institute of Medicine (IOM), a respected independent, nonprofit organization, established new standards for how guidelines should be developed. The goal was to increase the quality of guidelines and make them more trustworthy.
At the same time, the American Cancer Society evaluated its own process for creating cancer screening guidelines and decided to make its process consistent with the new IOM standards. A report on the new changes is published in the December 14, 2011 issue of the Journal of the American Medical Association.
Read the full news release at: http://tinyurl.com/c4sszg6
Source: The American Cancer Society
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
